Inflammasome mRNA expression in human monocytes during early septic shock

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 9, 2008, Pages 983-988

  Fahy, Ruairi J ^a,b   Exline, Matthew C ^a,b   Gavrilin, Mikhail A ^a,b   Bhatt, Nitin Y ^a,b   Besecker, Beth Y ^a,b   Sarkar, Anasuya ^a,b   Hollyfield, Jennifer L ^a,b   Duncan, Michelle D ^a,b   Nagaraja, Haikady N ^a   Knatz, Nina L ^a,b   Hall, Mark ^a,b   Wewers, Mark D ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Inflammasome; Messenger RNA; Monocytes; NALP1; Septic shock

Indexed keywords

ASC PROTEIN; CASPASE 5; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MAIL PROTEIN; MESSENGER RNA; NACHT LEUCINE RICH REPEAT AND PYRIN DOMAIN CONTAINING 1 PROTEIN; NACHT LEUCINE RICH REPEAT AND PYRIN DOMAIN CONTAINING 3 PROTEIN; PROTEIN; PROTEIN RIP2; PYPAF 7 PROTEIN; PYRIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; APOPTOSIS REGULATORY PROTEIN; CYTOSKELETON PROTEIN; NLRP1 PROTEIN, HUMAN; NLRP12 PROTEIN, HUMAN; PYCARD PROTEIN, HUMAN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DEMOGRAPHY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INTENSIVE CARE UNIT; MALE; MONOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SEPTIC SHOCK; SURVIVAL; APOPTOSIS; BIOSYNTHESIS; COMPARATIVE STUDY; CRITICAL ILLNESS; ENZYMOLOGY; FOLLOW UP; GENETICS; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOLOGY; TIME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 1; CRITICAL ILLNESS; CYTOSKELETAL PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TIME FACTORS;

EID: 42949162029     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200703-418OC     Document Type: Article

References (34)

1. Anderson RN, Smith BL. Deaths: leading causes for 2002. Natl Vital Stat Rep 2005;53:1-89.
2. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-172.
3. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996;125:680-687.
4. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995;21:S258-S263.
5. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989;17:975-978.
6. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 2003;35:535-544.
7. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891.
8. van Furth R. Monocyte production during inflammation. Comp Immunol Microbiol Infect Dis 1985;8:205-211.
9. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
10. Burns K, Martinon F, Tschopp J. New insights into the mechanism of IL-1beta maturation. Curr Opin Immunol 2003;15:26-30.
11. Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005;560:11-18.
12. Dinarello CA. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme. Ann N Y Acad Sci 1998;856:1-11.
13. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol Cell 2002;10:417-426.
14. Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S, Sagara J, Fernandes-Alnemri T, Alnemri ES. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 2005;13:236-249.
15. Seshadri S, Duncan MD, Hart JM, Gavrilin MA, Wewers MD. Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1β processing and release. J Immunol 2007;179:1274-1281.
16. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003;4:95-104.
17. Ting JP, Davis BK. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 2004;23:387-414.
18. Sarkar A, Duncan M, Hart J, Hertlein E, Guttridge DC, Wewers MD. ASC directs NF-κB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J Immunol 2006;176:4979-4986.
19. Scott AM, Saleh M. The inflammatory caspases: guardians against infections and sepsis. Cell Death Differ 2007;14:23-31.
20. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, et al. Mice deficient in IL-1beta-converting enzyme are defective in production of mature IL-1beta and resistant to endotoxic shock. Cell 1995;80:401-411.
21. Sarkar A, Hall MW, Exline M, Hart J, Knatz N, Gatson N, Wewers MD. Caspase-1 regulates E. coli sepsis and splenic B cell apoptosis independently of IL-1β and IL-18. Am J Respir Crit Care Med 2006;174:1003-1010.
22. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004;429:75-79.
23. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, Droin N, Ulevitch RJ, Green DR, Nicholson DW. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006;440:1064-1068.
24. Joshi VD, Kalvakolanu DV, Hasday JD, Hebel RJ, Cross AS. IL-18 levels and the outcome of innate immune response to lipopolysaccharide: importance of a positive feedback loop with caspase-1 in IL-18 expression. J Immunol 2002;169:2536-2544.
25. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
26. Gavrilin MA, Bouakl IJ, Knatz NL, Duncan MD, Hall MW, Gunn JS, Wewers MD. Internalization and phagosome escape required for Francisella to induce human monocyte IL-1β processing and release. Proc Natl Acad Sci USA 2006;103:141-146.
27. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003;168:165-172.
28. Martinon F, Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005;26:447-454.
29. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-574.
30. Kim HJ, Hart J, Knatz N, Hall MW, Wewers MD. Janus kinase 3 downregulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10. J Immunol 2004;172:4948-4955.
31. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995;85:1341-1347.
32. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997;3:678-681.
33. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006;38:240-244.
34. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007;356:1216-1225.